Peptide-Based Vectors

References:

1.         Kawamura KS, Sung M, Bolewska-Pedyczak E. and Gariépy J. (2006). Probing the impact of valency on the routing of arginine-rich peptides into eukaryotic cells. Biochemistry 45;1116-27.

2.         Sung M, Poon GM and Gariépy J. (2006). The importance of valency in enhancing the import and cell routing potential of protein transduction domain-containing molecules. Biochim Biophys Acta 1758;355-63.

3.         Bisland SK, Singh D and Gariépy J. (1999). Potentiation of chlorin e6 photodynamic activity in vitro with peptide-based intracellular vehicles. Bioconjug. Chem. 10;982-92.

4.         Kawamura KS, Su RC, Nguyen LT, Elford AR, Ohashi PS and Gariépy J. (2002). In vivo generation of cytotoxic T cells from epitopes displayed on peptide-based delivery vehicles. J. Immunol. 168; 5709-15.

5.         Sheldon K, Liu D, Ferguson J and Gariépy J. (1995). Loligomers: design of de novo peptide-based intracellular vehicles. Proc. Natl. Acad. Sc.i U.S.A. 92;2056-60.

6.         Singh D, Bisland SK, Kawamura K and Gariépy J. (1999). Peptide-based intracellular shuttle able to facilitate gene transfer in mammalian cells. Bioconjug. Chem. 10;745-54.

7.         Singh D, Kiarash R, Kawamura K, LaCasse EC and Gariépy J. (1998). Penetration and intracellular routing of nucleus-directed peptide-based shuttles (loligomers) in eukaryotic cells. Biochemistry 37;5798-809.

8.         Waschuk SA, Poon GMK and Gariépy J. (2007). Lego-like strategy for assembling multivalent peptide-based vehicles able to deliver molecular cargoes into cells. In Handbook of Cell-Penetrating Peptides 2nd edit. (Langel, U., ed.). CRC Press, Boca Raton.

9.         Poon GM, Brokx RD, Sung M and Gariépy J. (2007). Tandem dimerization of the human p53 tetramerization domain stabilizes a primary dimer intermediate and dramatically enhances its oligomeric stability. J Mol Biol 365;1217-31.

10.       Poon GM and Gariépy J. (2007). Cell-surface proteoglycans as molecular portals for cationic peptide and polymer entry into cells. Biochem Soc Trans 35;788-93.

11.       Gariépy J (2001). The use of Shiga-like toxin 1 in cancer therapy. Crit Rev Oncol Hematol 39;99-106.

12.       Gariépy J and Kawamura K. (2001). Vectorial delivery of macromolecules into cells using peptide-based vehicles. Trends Biotechnol 19;21-8.

13.       Brokx RD, Bisland SK and Gariépy J. (2002). Designing peptide-based scaffolds as drug delivery vehicles. J Control Release 78;115-23.

14.       Kodama K, Katayama Y, Shoji Y and Nakashima H. (2006). The features and shortcomings for gene delivery of current non-viral carriers. Curr Med Chem 13;2155-61.

15.       Khalil IA, Kogure K, Akita H and Harashima H. (2006). Uptake Pathways and Subsequent Intracellular Trafficking in Nonviral Gene Delivery. Pharmacol Rev 58;32-45.

16.       Kim TI, Baek JU, Yoon JK, Choi JS, Kim K and Park JS. (2007). Synthesis and Characterization of a Novel Arginine-Grafted Dendritic Block Copolymer for Gene Delivery and Study of Its Cellular Uptake Pathway Leading to Transfection. Bioconjugate Chem. 18;309-317.

17.       Eguchi A, Akuta T, Okuyama H, Senda T, Yokoi H, Inokuchi H, Fujita S, Hayakawa T, Takeda K, Hasegawa M and Nakanishi M. (2001). Protein Transduction Domain of HIV-1 Tat Protein Promotes Efficient Delivery of DNA into Mammalian Cells. J. Biol. Chem. 276;26204-26210.

18.       Noguchi H and Matsumoto S. (2006). Protein transduction technology: a novel therapeutic perspective. Acta Med Okayama 60;1-11.

19.       Wadia JS and Dowdy SF (2002). Protein transduction technology. Curr Opin Biotechnol 13;52-6.

20.       Chen J, Li G, Lu J, Chen L, Huang Y, Wu H, Zhang J and Lu D. (2006). A novel type of PTD, common helix-loop-helix motif, could efficiently mediate protein transduction into mammalian cells. Biochem Biophys Res Commun 347;931-40.

21.       Derossi D, Joliot AH, Chassaing G and Prochiantz A. (1994). The third helix of the Antennapedia homeodomain translocates through biological membranes. J Biol Chem 269;10444-50.

22.       Dilber MS, Phelan A, Aints A, Mohamed AJ, Elliott G, Smith CI and O'Hare P. (1999). Intercellular delivery of thymidine kinase prodrug activating enzyme by the herpes simplex virus protein, VP22. Gene Ther 6;12-21.

23.       Ford KG, Souberbielle BE, Darling D and Farzaneh F. (2001). Protein transduction: an alternative to genetic intervention? Gene Ther 8;1-4.

24.       Mitchell DJ, Kim DT, Steinman L, Fathman CG and Rothbard JB (2000). Polyarginine enters cells more efficiently than other polycationic homopolymers. J Pept Res 56;318-25.

25.       Noguchi H, Bonner-Weir S, Wei FY, Matsushita M and Matsumoto S. (2005). BETA2/NeuroD Protein Can Be Transduced Into Cells Due to an Arginine- and Lysine-Rich Sequence. Diabetes 54;2859-2866.

26.       Noguchi H, Matsumoto S, Okitsu T, Iwanaga Y, Yonekawa Y, Nagata H, Matsushita M, Wei FY, Matsui H, Minami K, Seino S, Masui Y, Futaki S and Tanaka K. (2005). PDX-1 Protein Is Internalized by Lipid Raft-Dependent Macropinocytosis. Cell Transplantation 14;637-645.

27.       Phelan A, Elliott G and O'Hare P. (1998). Intercellular delivery of functional p53 by the herpesvirus protein VP22. Nat Biotechnol 16;440-3.

28.       Sloots A and Wels WS. (2005). Recombinant derivatives of the human high-mobility group protein HMGB2 mediate efficient nonviral gene delivery. Febs J 272;4221-36.

29.       Vives E, Brodin P, and Lebleu B. (1997). A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 272;16010-7.